CRISPR and IPS cells are two of my favorite things so when they come together as in a cool, new paper from Sheng Ding’s lab, I’m excited to read it and curious as to what the scoop is. Since 2006-2007 when mouse and human reprogramming were first reported, many different methods have been explored to […]
CRISPR to make IPS cells: review of new Ding lab paper Read More »
A new Cell paper from Juan Carlos Izpisua Berlmonte’s group has made headlines about anti-aging across the globe because it suggests that the four core induced pluripotent stem cell (IPSC) factors use by Shinya Yamanaka to make IPSC can reverse aging. I’ve pasted the graphical abstract from the paper below and done a quick journal club style
Quick journal club on IPSC anti-aging paper: cool, but outstanding questions Read More »
By Samantha Yammine, PhD Candidate in Derek van der Kooy’s lab at the University of Toronto. See tweets live from #TMM2016 via @SamanthaZY here. Last week, 430 Canadian scientists, trainees, industry professionals, science communicators and international guests gathered in the picturesque ski town of Whistler, British Columbia for the annual Till & McCulloch meeting (TMM).
The day of plenary is the most enjoyable in my view including at ISSCR 2015 on the first day with a Yamanaka talk. You don’t need to make the choice between sessions and the judgement on the viability of shifting sessions versus staying put and listening to the slightly less relevant. ISSCR 2015 plenary was,
Overview of Yamanaka Talk at #ISSCR2015 by Heather Main Read More »
StemCells Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to do an interview and they graciously accepted. Below is the interview with CFO Greg Schiffman (picture at left from LinkedIn) including what I thought
Interview with StemCells Inc. leadership on hot topics Read More »
The recent publication of two Nature papers by a team in part led by Dr. Charles Vacanti on acid treatment produced stem cells (so-called STAP stem cells) has been a blockbuster story in the stem cell field and has grabbed major global media attention as well. For background my review of the paper here and more thoughts here. Many
Interview with Charles Vacanti on STAP Cells: Link to Spore Stem Cells & More Read More »
Nominations for Stem Cell Person of the Year 2013 closed last night and I ended up with a remarkable list of 30 nominees. I have included a few sentences about each one below, often taking verbiage directly from the nominator. The online voting on these nominees will start soon. The top vote getters will move
Here’s an updated 2013 look at protecting one’s own existing stem cells. Regenerative medicine is very exciting. But what’s even better than regenerative medicine? Preventative medicine. If one can prevent a problem from occurring in the first place, it is far better than trying to treat it after the fact. Of course in many cases
5 ways to protect your stem cells to stay healthy & younger Read More »
It’s Friday so time for some stem cell headlines. TGIF….although of course the stem cells will be growing, experiments going, the grants and papers continue being written, and data still analyzed on Saturdays and Sundays too in the stem cell field. Stem cells are not a Mon-Fri, 9-5 kind of universe, but most of you
TGIF: musings on recent stem cell headlines: some good, some stupid Read More »
This is a guest post on ISSCR 2013. By Dr. Susan Lim A record 4100 delegates attended the 11th Annual Meeting of the International Society for Stem Cell Research (ISSCR), held at the Convention and Exhibition Center in Boston from 12-15 June 2013. Co-sponsored by the Harvard Stem Cell Institute, the Meeting featured 7 Plenary
Delightful overview of ISSCR 2013 by guest blogger Dr. Susan Lim Read More »